REVIVO Biosystems provides human skin models and testing services for research and product development.
Founded in 2019 and based in Singapore, REVIVO Biosystems develops 4D human skin models and testing services for chemical, cosmetic, and pharmaceutical research. Its platform supports in vitro and ex vivo testing and offers an alternative to animal testing. Customers include cosmetic manufacturers, pharmaceutical and biotech firms, academic labs, CROs, and ingredient providers. In November 2021, it raised an undisclosed venture investment from Evonik Venture Capital.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in